当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第6期
编号:13239779
CHPPC联合静脉化疗对老年进展期胃癌患者血清OPN、nm23H1蛋白表达的影响(4)
http://www.100md.com 2018年2月25日 《中国医药导报》 2018年第6期
     [14] Song K,Liu N,Yang Y,et al. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262 [J]. Tumour Biol,2016,37(5):6493-6499.

    [15] Yun-Feng,Zhou,Liang,et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies [J]. World J Gastroentero,2016,22(30):6906-6916.

    [16] 李華强,郭春芳.OPN、B7-H4在上皮性卵巢癌患者血清中的表达及临床意义[J].局解手术学杂志,2016,25(12):867-870.

    [17] Sun SJ,Wu CC,Sheu GT,et al. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth [J]. Oncotarget,2016,7(34):55 572-55 579.

    [18] Ostheimer C,Schweyer F,Reese T,et al. The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer [J]. Oncol Lett,2016,12(5):3449-3456.

    [19] 唐泽飞,李春鸣.nm23重组质粒与肿瘤关系研究进展[J].中华实用诊断与治疗杂志,2016,30(1):12-14.

    [20] Kim I,Cheung DY,Jin IK,et al. Risk factors of lymph node metastasis in undifferentiated early gastric cancers [J]. J Clin Oncol,2017,35(4):171.

    [21] 任羽,贺爱军,葛繁梅.nm23-H1蛋白在急性髓细胞白血病患者中的表达及其疗效[J].实用临床医药杂志,2016, 20(5):43-45.

    [22] 邱亚,杨湛.肿瘤转移抑制基因nm23/NDPK的结构与功能[J].西部医学,2006,18(5):654-656.

    (收稿日期:2017-12-27 本文编辑:万 平), http://www.100md.com(杨本鑫 杜园 聂双发 李磊 费建东)
上一页1 2 3 4